Overview
TMCI market data
Price History
TMCI price chart · 1M
- O
- 4.74
- H
- 4.78
- L
- 4.42
- C
- 4.61
- Vol
- 14,125.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $4.74
- Previous Close
- $4.73
- Day High
- $4.78
- Day Low
- $4.42
- 52 Week High
- $5.14
- 52 Week Low
- $1.72
- 7 Day Return
- +3.71%
- 30 Day Return
- +14.96%
- 90 Day Return
- +33.04%
- 1 Year Return
- +161.93%
- Daily Notional Volume
- $65.1K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.93 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -29.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.17 – $7.65 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $293.3M · P/B 1.79 · P/S 1.41.
Company News
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5Benzinga · Aug 10, 2026, 6:21 PM
Treace Medical Concepts shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.Benzinga · Aug 7, 2026, 12:45 PM
8-K filing — TREACE MEDICAL CONCEPTS, INC. (TMCI)SEC EDGAR · Aug 7, 2026, 11:10 AM
Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M EstimateBenzinga · Aug 7, 2026, 11:06 AM
Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M EstBenzinga · Aug 7, 2026, 11:05 AM
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4Benzinga · Jul 16, 2026, 5:06 PM
Treace Medical Concepts Announces Completion Of First Case Utilizing Its HyperPlate XM Dynamic Compression Locking Implant, Complete Commercialization Expected in Q3 of 2026Benzinga · Jun 18, 2026, 11:15 AM